| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |